Intermediate-term outcomes with early steroid withdrawal in African-American renal transplant recipients undergoing surveillance biopsy

Surgery

Volumn 142, Issue 4, 2007, Pages 538-545

  Zeng, Xu ^a   El Amm, Jose M ^b   Doshi, Mona D ^b   Singh, Atul ^b   Morawski, Katherina ^c   Cincotta, Elizabeth ^d   Losanoff, Julian E ^c   West, Miguel S ^c   Gruber, Scott A ^c  

^a Department of Laboratory Medicine and Pathology ^*  (United States)

^b Division of Nephrology   (United States)

^c Section of Vascular Surgery   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CREATININE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; COURSE EVALUATION; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; TUBULAR DYSFUNCTION;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; AFRICAN AMERICANS; BIOPSY; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; KIDNEY TRANSPLANTATION; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 35348814289     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.07.006     Document Type: Article

References (23)

1. Ratcliffe P.J., Dudley C.R., Higgins R.M., Firth J.D., Smith B., and Morris P.J. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 348 (1996) 643-648
2. Ahsan N., Hricik D., Matas A., Rose S., Tomlanovich S., Wilkinson A., et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 68 (1999) 1865-1874
3. Opelz G., Dohler B., and Laux G. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 5 (2005) 720-728
4. Elias T.J., Bannister K.M., Clarkson A.R., Russ G.R., Mathew T.H., Barratt L.J., et al. Excellent long-term graft survival in low risk, primary renal allografts treated with prednisolone-avoidance immunosuppression. Clin Transplant 14 (2000) 157-161
5. Birkeland S.A. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients. Transplantation 71 (2001) 1089-1090
6. Matas A.J., Kandaswamy R., Gillingham K.J., McHugh L., Ibrahim H., Kasiske B., et al. Prednisone-free maintenance immunosuppression-a five-year experience. Am J Transplant 5 (2005) 2473-2478
7. Kaufman D.B., Leventhal J.R., Axelrod D., Gallon L.G., Parker M., and Stuart F.P. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction- long-term results. Am J Transplant 5 (2005) 2539-2548
8. Young C.J., and Gaston R.S. Renal transplantation in black Americans. N Engl J Med 343 (2000) 1545
9. Gruber S.A., West M.S., Sillix D.H., El-Amm J.M., Garnick J., Morawski K., et al. Preliminary results with early corticosteroid withdrawal in African-American renal allograft recipients. Surgery 138 (2005) 772-779
10. Haririan A., Sillix D.H., Morawski K., El-Amm J.M., Garnick J., Doshi M.D., et al. Short-term experience with early steroid withdrawal in African-American renal transplant recipients. Am J Transplant 6 (2006) 2396-2402
11. Haririan A., Morawski K., Sillix D.H., El-Amm J.M., Garnick J., West M., et al. Induction therapy with basiliximab versus thymoglobulin in African-American kidney transplant recipients. Transplantation 79 (2005) 716-721
12. Flechner S.M., Friend P.J., Brockmann J., Ismail H.R., Zilvetti M., Goldfarb D., et al. Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steriod-free kidney transplant immunosuppression. Am J Transplant 5 (2005) 3009-3014
13. Gelens M.A.C.J., Christiaans M.H.L., van Heurn E.L.W., van den Berg-Loonen E.P.M., Peutz-Kootstra C.J., and van Hooff J.P. High rejection rate during calcineurin inhibitor-free and early steroid withdrawal immunosuppression in renal transplantation. Transplantation 82 (2006) 1221-1223
14. Woodle E.S., Vincenti F., Lorber M.I., Gritsch H.A., Hricik D., Washburn K., et al. A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under Simulect, tacrolimus and sirolimus. Am J Transplant 5 (2005) 157-166
15. Anil Kumar M.S., Heifets M., Fyfe B., Saaed M.I., Moritz M.J., Parikh M.H., et al. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 80 (2005) 807-814
16. Matas A.J., Kandaswamy R., Humar A., Payne W.D., Dunn D.L., Najarian J.S., et al. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg 240 (2004) 510-516
17. Khwaja K., Asolati M., Harmon J., Melancon J.K., Dunn T., Gillingham K., et al. Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. Am J Transplant 4 (2004) 980-987
18. Boardman R.E., Alloway R.R., Alexander J.W., Buell J.F., Cardi M., First M.R., et al. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant 5 (2005) 356-365
19. Anil Kumar M.S., Moritz M.J., Saaed M.I., Heifets M., Sustento-Reodica N., Fyfe B., et al. Avoidance of chronic steroid therapy in African American kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am J Transplant 5 (2005) 1976-1985
20. Gruber S.A. Subclinical acute rejection treated as clinical acute rejection: same intervention, same morbidity, masked endpoint, equal reporting. Transplantation 82 (2006) 1550-1551
21. Heilman R.L., Reddy K.S., Mazur M.J., Moss A.A., Post D.J., Petrides S., et al. Acute rejection risk in kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab. Transplant Proc 38 (2006) 1307-1313
22. Laftavi M.R., Stephan R., Stefanick B., Kohli R., Dagher F., and Applegate M. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Surgery 13 (2005) 364-371
23. Nankivell B.J., Borrows R.J., Fung C.L.-S., O'Connell P.J., Allen R.D.M., and Chapman J.R. The natural history of chronic allograft nephropathy. N Eng J Med 349 (2003) 2326-2333